IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Journal of Immunology (52:12) - New York, NY : Wiley - S. 1972-1979
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Technische Universität Berlin
- (when)
-
2022
- Creator
-
Meltendorf, Stefan
Vogel, Katrin
Thurm, Christoph
Prätsch, Florian
Reinhold, Annegret
Färber, Jacqueline
Heuft, Hans-Gert
Kaasch, Achim J.
Hachenberg, Thomas
Weinzierl, Stefan
Schraven, Burkhart
Reinhold, Dirk
Brunner-Weinzierl, Monika
Lingel, Holger
- DOI
-
10.14279/depositonce-16666
- Handle
-
11303/17877
- URN
-
urn:nbn:de:101:1-2022122800583825202555
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meltendorf, Stefan
- Vogel, Katrin
- Thurm, Christoph
- Prätsch, Florian
- Reinhold, Annegret
- Färber, Jacqueline
- Heuft, Hans-Gert
- Kaasch, Achim J.
- Hachenberg, Thomas
- Weinzierl, Stefan
- Schraven, Burkhart
- Reinhold, Dirk
- Brunner-Weinzierl, Monika
- Lingel, Holger
- Technische Universität Berlin
Time of origin
- 2022
Other Objects (12)
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
The mRNA stability Regulator Khd4 determines infectious hyphae development in Ustilago maydis
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Systemic vaccination with aluminum hydroxide induces protective immunity against Helicobacter pylori infection in mice
Addressing key challenges for unlocking T cell-mediated immunity through peptide vaccination against cancer
DC-SIGN and Immunity: the role of human DC-SIGN during anti-fungal immunity and as a targeting molecule for vaccination strategies
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Non-invasive vaccination by nanoparticle-based messenger RNA (mRNA) delivery via the transfollicular route
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
The mRNA stability Regulator Khd4 determines infectious hyphae development in Ustilago maydis
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Systemic vaccination with aluminum hydroxide induces protective immunity against Helicobacter pylori infection in mice
Addressing key challenges for unlocking T cell-mediated immunity through peptide vaccination against cancer
DC-SIGN and Immunity: the role of human DC-SIGN during anti-fungal immunity and as a targeting molecule for vaccination strategies
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Non-invasive vaccination by nanoparticle-based messenger RNA (mRNA) delivery via the transfollicular route
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
The mRNA stability Regulator Khd4 determines infectious hyphae development in Ustilago maydis
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Systemic vaccination with aluminum hydroxide induces protective immunity against Helicobacter pylori infection in mice
Addressing key challenges for unlocking T cell-mediated immunity through peptide vaccination against cancer
DC-SIGN and Immunity: the role of human DC-SIGN during anti-fungal immunity and as a targeting molecule for vaccination strategies
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Non-invasive vaccination by nanoparticle-based messenger RNA (mRNA) delivery via the transfollicular route